This work will focus on the proteins involved in the replication of adenovirus DNA. Specifically, DNA encoding these proteins will be moved onto bacterial plasmids which will allow expression of the viral DNA in bacteria. The proteins of interest are the E2b terminal protein, the E2b encoded polymerase and the 72K DBP from region E2a. These proteins will be synthesized as fusion products containing less than 15 amino acids, and in some cases only 1, from the Beta-galactosidase gene of E. coli or the cro gene of lambda. The microbially synthesized products will be purified and tested in vitro for their ability to function in adenovirus replication assays. Subsequently, specific modifications will be made in the primary structure of these proteins by altering the DNA encoding them. The effect of these alterations on the activity and properties of these proteins will then be tested. Conditional lethal mutations in the adenovirus terminal protein as well as additional mutations within the 120k polymerase gene will also be created in intact virus. These mutations will be characterized for their effect on viral DNA replication and on the virus growth cycle. We will also create antisera against these proteins by utilizing synthetic peptides as well as fragments of the proteins synthesized in bacteria as antigens. These sera will be used to study the synthesis and role of the replication proteins in the infected HeLa cell.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Modified Research Career Development Award (K04)
Project #
5K04CA000905-05
Application #
3071499
Study Section
Virology Study Section (VR)
Project Start
1985-02-01
Project End
1990-01-31
Budget Start
1989-02-01
Budget End
1990-01-31
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Type
School of Medicine & Dentistry
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Clark, Mary C; Baum, Linda G (2012) T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival. Ann N Y Acad Sci 1253:58-67
Mandelblatt, Jeanne S; Stout, Natasha; Trentham-Dietz, Amy (2011) To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Ann Intern Med 155:58-60
McElroy, T C; Kandl, K L; Garcia, J et al. (2003) Extinction-colonization dynamics structure genetic variation of spotted sunfish (Lepomis punctatus) in the Florida Everglades. Mol Ecol 12:355-68
van Keulen, H; Mertz, P M; LoVerde, P T et al. (1991) Characterization of a 54-nucleotide gap region in the 28S rRNA gene of Schistosoma mansoni. Mol Biochem Parasitol 45:205-14
Mertz, P M; Bobek, L A; Rekosh, D M et al. (1991) Schistosoma haematobium and S. japonicum: analysis of the ribosomal RNA genes and determination of the ""gap"" boundaries and sequences. Exp Parasitol 73:137-49
Smith, A J; Cho, M I; Hammarskjold, M L et al. (1990) Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J Virol 64:2743-50
Lu, X B; Heimer, J; Rekosh, D et al. (1990) U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci U S A 87:7598-602
Lewis, N; Williams, J; Rekosh, D et al. (1990) Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J Virol 64:1690-7
Miller, S; Rekosh, D M; LoVerde, P T (1989) Schistosoma mansoni: identification and characterization of schistosomula polypeptides. Exp Parasitol 69:249-62
Spotila, L D; Hirai, H; Rekosh, D M et al. (1989) A retroposon-like short repetitive DNA element in the genome of the human blood fluke, Schistosoma mansoni. Chromosoma 97:421-8

Showing the most recent 10 out of 18 publications